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Providencia rettgeri is a member of the Enterobacteriaceae, known to 
cause urinary tract infections (UTIs), bacteraemia, skin infect ions, 
gastroenteritis and wound infections, especially in immunocom-
promised patients and those with indwelling urinary catheters.[1-3] 
P. rettgeri is an aerobic Gram-negative bacillus that displays marked 
resistance to most of the currently available antibiotics.[2] The organ-
ism is part of the normal gastrointestinal flora.[3] 
Immunocompromised or debilitated patients are highly suscep-
tible to hospital-acquired infections – either after colonisation with 
environmental strains or following invasive procedures, such as 
catheterisation, bronchoscopy, colposcopy or surgical biopsies.[4] 
P. rettgeri is commonly found to cause traveller’s diarrhoea and 
has also been isolated from more severe human infections such as 
meningitis.[3,5,6] 
Among the Providencia species, P. stuartii and P. rettgeri are the 
most common causes of infections, especially UTIs in hospitalised 
patients, although other infections can occur. Virtually all Providencia 
species can produce inducible AmpC beta-lactamases, and many iso-
lates may also produce extended-spectrum beta-lactamases (ESBLs) 
in nosocomial settings.[3] 
P. rettgeri has been associated with hospital-acquired infections, 
including catheter-related UTIs. Multiple factors contribute to the 
high frequency of UTIs in hospitalised patients. Comorbid illnesses 
and interventions to manage bladder voiding are the most impor-
tant contributing variables. Prostatic hypertrophy in men promotes 
infection through urethral obstruction and turbulent urine flow and 
the additional risks associated with the use of instruments. Bacterial 
prostatitis, once established, is difficult to eradicate and may be a 
source of recurrent UTI over many years.[7]
The emergence of resistance to multiple antimicrobial agents in 
pathogenic bacteria has become a significant public health threat, 
as there are fewer and sometimes no effective antimicrobial agents 
available for infections caused by multidrug-resistant bacteria.[8] 
The mechanism of resistance of Enterobacteriaceae to carbapen-
ems is most commonly by the production of an enzyme that breaks 
down the antibiotic before it can affect the bacterium.[9] Resistance 
to antimicrobial agents in several bacteria is increasing, often 
because of poor application of antibiotic stewardship. Antimicrobial 
resistance is destroying the premise of modern medicine, i.e. 
whenever required, adequate antibiotic cover is available to save 
the patient’s life.[10] The emergence of carbapenem resistance in 
Providencia species is of particular concern because these bacteria 
are intrinsically resistant to polymyxins and tigecycline.[11] These 
antibiotics are often used as part of regimens in the treatment of 
carbapenem-resistant isolates.
New Delhi metallo-beta-lactamase-1 (NDM-1)-mediated carbapen-
emase is the most common class B carbapenemase in Enterobacteriaceae 
and has been detected increasingly in several countries.[12] The broad dis-
tribution of NDM-producing isolates and the apparent ease of transfer 
of the blaNDM gene are a major threat to public health globally.[13] 
P. rettgeri has recently been recognised as a key organism for the dissemi-
nation of NDM-1, requiring measures for timely control of the spread of 
this organism.[14] Our objective was to characterise a cluster of identified 
carbapenem-resistant P. rettgeri and determine the epidemiological link 
of the isolates. 
Methods
A P. rettgeri outbreak was identified at Steve Biko Academic Hospital 
(SBAH), Pretoria, South Africa between November 2014 and January 
2015. SBAH is a tertiary hospital with referrals from lower-level 
hospitals in the Tshwane municipal area. The urine samples were 
obtained from patients admitted to SBAH and the analysis was 
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conducted at the medical microbiology laboratory of the Tshwane 
Academic Division of the National Health Laboratory Service (NHLS).
Ethical clearance was given by the Faculty of Health Sciences 
Research Ethics Committee, University of Pretoria (ref. no. 247/2015).
Bacteria isolation and identification 
A loopfull of urine was streaked on blood agar and MacConkey agar 
media. The culture plates were incubated at 35±2°C for 18 - 24 hours. 
Plates that showed growth were observed and the colonies were fur-
ther identified using the Vitek 2 system (bioMérieux, USA). 
Antibiotic susceptibility test
The following antibiotics were tested by the disc diffusion method: 
ampicillin (10 µg), amoxicillin-clavulanic acid (30 µg), cefotaxime 
(30 µg), ceftazidime (30 µg), cefoxitin (30 µg), imipenem (10 µg), 
meropenem (10 µg), ertapenem (10 µg), cefuroxime (30 µg), cipro-
floxacin (5 µg), and trimethoprim/sulfamethoxazole (25 µg). The 
isolates were inoculated on Mueller-Hinton agar and the antibiotic 
discs were placed on the agar surfaces. The plates were incubated at 
35±2°C for 18 - 24 hours. The susceptibility was read after 24 hours’ 
incubation as per 2015 Clinical and Laboratory Standards Institute 
guidelines.
Detection of ESBL production was determined among the Gram-
negative bacteria resistant to third-generation cephalosporins by the 
double-disc synergy test, with ceftazidime (30 µg) and cefotaxime (30 µg) 
discs placed 20 mm centre-to-centre around an amoxicillin-clavulanic 
acid (30 µg) disc. This was done on the surface of a Mueller-Hinton agar 
plate inoculated with the isolates’ suspension equivalent to 0.5 McFarland 
standards by surface spreading using sterile swab sticks. After incubation 
at 35±2°C for 24 hours, ESBL production was inferred when the zone 
of inhibition around the cephalosporin discs was expanded by ≥5 mm 
by the presence of clavulanic acid. Carbapenem resistance was defined 
by reduced susceptibility to imipenem, ertapenem and meropenem. 
Carbapenem resistance was characterised for carbapenemase production 
by the modified Hodge test.
Results
A total of 4 isolates were collected from patients who were admitted 
to the intensive care unit (ICU) and high-care unit. Clinical and 
demographic characteristics of the 4 patients with carbapenem-
resistant P. rettgeri are outlined in Table 1. 
Case 1
An HIV-positive 26-year-old woman who was not yet receiving 
treatment was admitted to the ICU with a respiratory tract infection. 
While in the ICU, she developed renal failure and received dialysis. 
After 2 months she presented with pyrexia, haematuria and positive 
urine nitrites. A urine sample was submitted to the laboratory for 
culture, where P. rettgeri was isolated. 
Case 2
An HIV-positive 32-year-old woman was admitted to the ICU a 
month after Case 1; they shared the ICU. She had renal failure with 
pulmonary oedema and received dialysis while there. A urine sample 
was submitted to the laboratory a month later for a suspected UTI; 
P. rettgeri was isolated. After 2 months in the ICU the patient was 
transferred to the high-care unit, where she continued receiving 
treatment for renal failure. 
Case 3
A 40-year-old man with known hypertension was admitted to the 
same high-care unit as Case 2. He presented with renal failure, for 
which he received dialysis. Four days after admission he complained 
of symptoms suggestive of a possible UTI. A midstream urine sample 
was collected and sent to the laboratory, where P. rettgeri was isolated. 
The patient was deemed stable and transferred to a regular ward to 
continue with renal failure treatment. 
Case 4
An HIV-positive 33-year-old woman was admitted to the surgical 
ICU with multiple gunshot wounds of the head and abdomen. The 
patient had a laparotomy, and a hysterectomy and nephrectomy were 
performed. Amoxicillin-clavulanic acid and metronidazole were 
administered after the operation to cover for possible contamination 
during surgery. While in the ICU, the patient developed bedsores on 
the sacral and occipital regions. Three weeks after admission, she was 
transferred to the high-care unit, where cases 2 and 3 were previously 
admitted. While in the high-care unit, a biopsy of the bedsore was 
sent to the laboratory, where P. rettgeri was isolated.
All P. rettgeri isolated in these cases had a carbapenem-resistant 
antibiogram with resistance to imipenem, ertapenem and meropenem. 
Discussion
The cases presented in this study demonstrated carbapenem-resistant 
P. rettgeri, which showed that they were epidemiologically linked. 
This may partly be explained by some of the carbapenem-resistant 
genes being known to be transmitted horizontally. This organism 
inhabits moist areas or moisture-containing instruments, such as 
dialysis machines, which may have been the main source in this 
outbreak. As some patients acquired the infection after they were 
discharged, transmission from inanimate objects and healthcare 
workers is a possibility.
Several studies have indicated that immune-compromised patients 
are more prone to UTIs – all of the cases reported here were immune-
Table 1. Clinical and demographic characteristics of 4 cases of carbapenem-resistant P. rettgeri
Case Sex
Age 
(years) Site of isolation
Antimicrobial 
therapy Treatment Outcome HIV status 
Reason for ward 
admission 
1 F 26 Urine Carbapenem Dialysis Transferred to 
high-care unit
Positive Respiratory 
infection
2 F 32 Urine Carbapenem Dialysis Discharged 
home
Positive Renal failure
3 M 40 Urine Carbapenem Dialysis Transferred to 
renal unit 
Negative Renal failure
4 F 33 Tissue Carbapenem Dialysis Died Positive Polytrauma
F = female; M = male.
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compromised.[1-3] Catheterisation is a predisposing factor for the 
development of a UTI and all patients investigated in this study had 
urinary catheterisation. All patients were also dialysed, which may 
have exposed them to fluids containing P. rettgeri. This association 
will require a larger study to provide conclusive evidence. 
Caution needs to be exercised when using common equipment, 
such as dialysis machines, to prevent the transfer of bacteria. 
Thorough sterilisation and cleaning of equipment is of paramount 
importance in the prevention of microbial contamination and 
infection. A point prevalence surveillance of colonisation must be 
conducted on a regular basis for early detection of environmental 
and equipment contamination. Cohorting of patients infected and 
colonised by resistant organisms may limit the spread of infection 
to other patients in the unit. Studies have demonstrated that 
isolating and cohorting infected or colonised patients with contact 
precautions, healthcare personnel hand hygiene and environmental 
cleaning are integral to the disruption of the spread of infection 
within the hospital setting.[15] 
Conclusion
The prevention and control of nosocomial infections depend on a 
multipronged approach, simultaneously targeting antibiotic steward-
ship, universal precautions and appropriate transmission-based pre-
caution practices. Education of healthcare personnel plays a pivotal 
role in preventing and controlling the outbreak. Hand hygiene and 
equipment sterilisation must be reiterated to healthcare personnel, as 
proper hygienic practices are important in the prevention of bacterial 
infections in a healthcare facility.
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